Abstract
Journal of Palliative MedicineVol. 12, No. 6 Letters to the EditorThe Feasibility of Using Intravenous Fentanyl as Sublingual Drops in the Treatment of Incidental Pain in Patients with CancerMohammad Bushnaq, Muhannad Al-Shoubaki, and Mohammed MilhemMohammad BushnaqPalliative Care Program, King Hussein Cancer Center, Amman, Jordan.Search for more papers by this author, Muhannad Al-ShoubakiPalliative Care Program, King Hussein Cancer Center, Amman, Jordan.Search for more papers by this author, and Mohammed MilhemDivision of Hematology and Oncology and Blood Marrow, Transplantation University of Iowa, Iowa City, IA.Search for more papers by this authorPublished Online:9 Jun 2009https://doi.org/10.1089/jpm.2009.9618AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byPalliative Sedation with Oral Medicines in an Infant with Generalized Severe Junctional Epidermolysis Bullosa Keith P. Pasichow, Meg Frizzola, and Elissa G. Miller1 July 2018 | Journal of Palliative Medicine, Vol. 21, No. 7Breathing is Not An Option; Dyspnea is19 December 2018 | Journal of Palliative Care, Vol. 30, No. 3Critical Appraisal of the Breakthrough Pain in Cancer4 July 2013Systematic review of the role of alternative application routes for opioid treatment for moderate to severe cancer pain: An EPCRC opioid guidelines project27 June 2011 | Palliative Medicine, Vol. 25, No. 5Current World LiteratureCurrent Opinion in Supportive & Palliative Care, Vol. 4, No. 1 Volume 12Issue 6Jun 2009 InformationCopyright 2009, Mary Ann Liebert, Inc.To cite this article:Mohammad Bushnaq, Muhannad Al-Shoubaki, and Mohammed Milhem.The Feasibility of Using Intravenous Fentanyl as Sublingual Drops in the Treatment of Incidental Pain in Patients with Cancer.Journal of Palliative Medicine.Jun 2009.511-514.http://doi.org/10.1089/jpm.2009.9618Published in Volume: 12 Issue 6: June 9, 2009PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
